@hottod it would be interesting to know how this drug performed in pre-clinical non-human primates and if the primates were much healthier (pre-dosing) compared to the human patient.
Ann: PYC Therapeutics Investor Call - 18 August 2022, page-24
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.5¢ | $2.648K | 25.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 627178 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 1883052 | 16 |
View Market Depth
| Last trade - 11.11am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.0¢ | 10.5¢ | 38180 | ||
| Last updated 10.50am 18/06/2024 ? | |||||
| PYC (ASX) Chart |
